What Researchers Did
This review summarized existing research on hyperbaric oxygen therapy (HBOT) as an adjunctive treatment for glioblastoma multiforme (GBM).
What They Found
Limited clinical trials and preclinical studies suggest that radiotherapy immediately after HBOT enhances radiotherapy effects, and HBOT can strengthen chemotherapy's anti-tumor effect when combined. HBOT was generally well tolerated in GBM patients and did not significantly increase toxicity.
What This Means for Canadian Patients
For Canadian patients with glioblastoma multiforme, hyperbaric oxygen therapy could potentially serve as a well-tolerated adjunctive treatment to improve the efficacy of existing radio-chemotherapy. This approach may offer a way to enhance current treatment outcomes without significantly increasing side effects.
Canadian Relevance
There is no direct Canadian connection mentioned in this review.
Study Limitations
The review was based on limited clinical trials and preclinical studies, with HBOT's role as a standalone curative strategy remaining controversial and not rigorously evaluated in patients.